Stephen K. Burley

Stephen K. Burley

Corporate Officer/Principal at
The Rockefeller University
68 year
Consumer Services
Health Technology
Technology Services

Profile

Stephen K.
Burley
is the founder of Prospect Genomics, Inc. He is currently an Adjunct Professor at The Rockefeller University.
Previously, he was the Director at Cascadian Therapeutics LLC in 2008 and the Chief Scientific Officer & SVP-Research at SGX Pharmaceuticals, Inc. from 2002 to 2011.
Burley received his doctorate degrees from Harvard University and the University of Oxford, and his undergraduate degree from the University of Western Ontario.

Stephen K. Burley active positions

CompaniesPositionStart
Corporate Officer/Principal 31/05/1997

Former positions of Stephen K. Burley

CompaniesPositionEnd
Chief Tech/Sci/R&D Officer 17/04/2011
CASCADIAN THERAPEUTICS INC (USA) Director/Board Member 03/09/2008
Founder -
See the detail of Stephen K. Burley's experience

Training of Stephen K. Burley

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

85

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Consumer Services

Consumer Services

Health Technology

Technology Services

Consumer Services

Consumer Services

  1. Stock Market
  2. Insiders
  3. Stephen K. Burley